Foamix Pharmaceuticals Ltd. Announces Closing of Its $69M Public Offering of Ordinary Shares
April 20, 2015 at 16:18 PM EDT
Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing ...